<table>
   <tr>
    <td>9.</td>
    <td>Reviewing and monitoring the auditor's independence and performance, and effectiveness of audit process</td>
   </tr>
   <tr>
    <td>10.</td>
    <td>Reviewing, with the management, the statement of uses/ application of funds raised through an issue (public issue, rights issue, preferential issue, etc.), the statement of funds utilised for purposes other than those stated in the offer document/ prospectus/ notice and the report submitted by the monitoring agency monitoring the utilisation of proceeds of a public or rights issue, and making appropriate recommendations to the Board to take up steps in this matter. This also includes monitoring the use/application of the funds raised through the proposed initial public offer by the Company;</td>
   </tr>
   <tr>
    <td>11.</td>
    <td>Approval or any subsequent modifications of transactions of the Company with related parties and omnibus approval for related party transactions proposed to be entered into by the Company, subject to the conditions as may be prescribed<br/>Explanation: The term "related party transactions" shall have the same meaning as provided in Clause 2(zc) of the SEBI Listing Regulations and/or the applicable Accounting Standards and/or the Companies Act, 2013;</td>
   </tr>
   <tr>
    <td>12.</td>
    <td>Reviewing, at least on a quarterly basis, the details of the related party transactions entered into by the Company pursuant to each of the omnibus approvals given;</td>
   </tr>
   <tr>
    <td>13.</td>
    <td>Laying down the criteria for granting omnibus approval in line with the Company's policy on related party transactions;</td>
   </tr>
   <tr>
    <td>14.</td>
    <td>Scrutinising of inter-corporate loans and investments;</td>
   </tr>
   <tr>
    <td>15.</td>
    <td>Valuation of undertakings or assets of the Company, wherever it is necessary;</td>
   </tr>
   <tr>
    <td>16.</td>
    <td>Evaluating of internal financial controls and risk management systems;</td>
   </tr>
   <tr>
    <td>17.</td>
    <td>Establishing a vigil mechanism for directors and employees to report their genuine concerns or grievances, with the chairman of the Audit Committee directly hearing grievances of victimization of employees and directors, who used vigil mechanism to report genuine concerns in appropriate and exceptional cases;</td>
   </tr>
   <tr>
    <td>18.</td>
    <td>Reviewing, with the management, the performance of statutory and internal auditors, and adequacy of the internal control systems;</td>
   </tr>
   <tr>
    <td>19.</td>
    <td>Reviewing the adequacy of internal audit function if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure coverage and frequency of internal audit;</td>
   </tr>
   <tr>
    <td>20.</td>
    <td>Discussing with internal auditors on any significant findings and follow up thereon;</td>
   </tr>
   <tr>
    <td>21.</td>
    <td>Reviewing the findings of any internal investigations by the internal auditors into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board;</td>
   </tr>
   <tr>
    <td>22.</td>
    <td>Discussing with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern;</td>
   </tr>
   <tr>
    <td>23.</td>
    <td>Recommending to the board of directors the appointment and removal of the external auditor, fixation of audit fees and approval for payment for any other services;</td>
   </tr>
   <tr>
    <td>24.</td>
    <td>Looking into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors;</td>
   </tr>
   <tr>
    <td>25.</td>
    <td>Reviewing the functioning of the whistle blower mechanism;</td>
   </tr>
  </table>

240